Search Results - "Paddenburg, Fred"

Safety and Humoral Immunogenicity of Different Dose Levels of Ad26.COV2.S as a 2-Dose Regimen in COVID-19 Vaccine-Naïve Healthy Adults: A Phase 3 Randomized Clinical Trial by Rezelj, Veronica V, Paddenburg, Fred, Diegbe, Marie Enajite, Nangosyah, Julius, Reisinger, Emil C, Hu, Weihong, Truyers, Carla, Scheper, Gert, Le Gars, Mathieu, Hendriks, Jenny, Struyf, Frank, Douoguih, Macaya, Schuitemaker, Hanneke, Ruiz-Guiñazú, Javier

“…This study aimed to support the end-of-shelf life specification (2.5 × 10 virus particles [vp]) for the standard Ad26.COV2.S dose (5 × 10 vp). This randomized,…”
Get full text

Abbreviated or Standard Antiplatelet Therapy After PCI in Diabetic Patients at High Bleeding Risk by Landi, Antonio, Heg, Dik, Chevalier, Bernard, Komiyama, Nobuyuki, Onuma, Yoshinobu, Peace, Aaron, Pyxaras, Stylianos, Xaplanteris, Panagiotis, Smits, Pieter C., Valgimigli, Marco, Smits, P.C., Van Es, G.A., Vos, G.B.W.E., Morice, M.C., Frigoli, E., Jüni, P., Ajit, M.S., Alasnag, M., Bartunek, J., Mahfoud, F., Rodriguez, A.E., Schultz, C., Tonino, P., Moschovitis, Aris, Bertrand, M., Pocock, S., Hanet, C., Radke, P., Paddenburg, Fred, van Vliet, Ria, Bakker, Chantal, Minagawa, Kazuhiro, Cura, Fernando, Jepson, Nigel, Whitbourn, Robert, Christopher Raffel, Owen, Weidinger, Franz, Dewilde, Willem, Barbato, Emanuele, Pourbaix, Suzanne, Mateev, Hristo, Kala, Petr, Mates, Martin, Delorme, Laurent, Cuisset, Thomas, Belle, Loïc, Beygui, Farzin, Koning, Rene, Valla, Mathieu, Cayla, Guillaume, Montalescot, Gilles, Guyon, Phillipe, Mahfoud, Felix, Stylianos, Pyxaras, Abhaichand, Rajpal K., Majdi, Halabi, Roguin, Ariel, Feld, Yair, Garducci, Stefano, Chieffo, Alaide, Tamburino, Corrado, Testa, Luca, Minervin, Gianluigi, Ando, Kenji, Matsuo, Hitoshi, Shimizu, Kiyokazu, Murohara, Toyoaki, Yamazaki, Seiji, Kedev, Sasko, Podolec, Jakub, Lesiak, Maciej, Wlodarczak, Adian, Alasnag, Mirvat, Mangovski, Ljupco, Stankovic, Goran, Debeljacki, Dragan, Park, Seung-Jung, Iniguez, Andrés, Garcia del Blanco, Bruno, Blazquez, Ivan Gomez, Escaned Barbosa, Javier, Sainz, Fermin, Goicolea, Javier, Moschovitis, Aris, Leibundgut, Gregor, Pedrazzini, Giovanni, Garachemani, Ali, Siegrist, Patrick, Jessurun, Ruifrok, Tonino, Pim, Kauer, Floris, von Birgelen, Clemens, Ijsselmuiden, Sander, Johnson, Tom, Routledge, Helen, Hildick-Smith, David, McDonald, John, Williams, Rupert, Nguyen, Ngoc Quang

“…Abbreviated antiplatelet therapy (APT) reduces bleeding without increasing ischemic events in largely unselected high bleeding risk (HBR) patients undergoing…”
Get full text

Abbreviated or Standard Dual Antiplatelet Therapy by Sex in Patients at High Bleeding Risk: A Prespecified Secondary Analysis of a Randomized Clinical Trial by Landi, Antonio, Alasnag, Mirvat, Heg, Dik, Frigoli, Enrico, Malik, Fazila Tun Nesa, Gomez-Blazquez, Ivan, Pourbaix, Suzanne, Chieffo, Alaide, Spaulding, Christian, Sainz, Fermin, Routledge, Helen, Andò, Giuseppe, Testa, Luca, Sciahbasi, Alessandro, Contractor, Hussain, Jepson, Nigel, Mieres, Juan, Imran, Syed Saqib, Noor, Husam, Smits, Pieter C, Valgimigli, Marco

“…Abbreviated dual antiplatelet therapy (DAPT) reduces bleeding with no increase in ischemic events in patients at high bleeding risk (HBR) undergoing…”
Get more information